BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18401015)

  • 1. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology.
    Brandes AA; Tosoni A; Spagnolli F; Frezza G; Leonardi M; Calbucci F; Franceschi E
    Neuro Oncol; 2008 Jun; 10(3):361-7. PubMed ID: 18401015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence.
    Parvez K; Parvez A; Zadeh G
    Int J Mol Sci; 2014 Jul; 15(7):11832-46. PubMed ID: 24995696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?
    Forsyth PA; Kelly PJ; Cascino TL; Scheithauer BW; Shaw EG; Dinapoli RP; Atkinson EJ
    J Neurosurg; 1995 Mar; 82(3):436-44. PubMed ID: 7861222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
    Yang I; Huh NG; Smith ZA; Han SJ; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):181-6. PubMed ID: 19944976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis?
    Peca C; Pacelli R; Elefante A; Del Basso De Caro ML; Vergara P; Mariniello G; Giamundo A; Maiuri F
    Clin Neurol Neurosurg; 2009 May; 111(4):331-4. PubMed ID: 19117668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment-induced tumor-like lesions in the course of neurooncological therapy].
    Bagó GA; Osztie E; Várallyay P; Fedorcsák I
    Magy Onkol; 2013 Dec; 57(4):240-50. PubMed ID: 24353989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoprogression after glioma therapy: a comprehensive review.
    Kruser TJ; Mehta MP; Robins HI
    Expert Rev Neurother; 2013 Apr; 13(4):389-403. PubMed ID: 23545054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of laryngeal radionecrosis].
    Morales C; del Valle A; Rubio A; Mazón A; Rama J
    Acta Otorrinolaringol Esp; 1997 May; 48(4):295-8. PubMed ID: 9376141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis.
    Nichelli L; Casagranda S
    Curr Opin Oncol; 2021 Nov; 33(6):597-607. PubMed ID: 34534142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategy of late cerebral radionecrosis. A retrospective study of 21 cases.
    Carangelo B; Cerillo A; Mariottini A; Peri G; Rubino G; Mourmouras V; Palma L
    J Neurosurg Sci; 2010 Mar; 54(1):21-8. PubMed ID: 20436395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
    Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
    Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating brain radionecrosis from tumour recurrence: a role for contrast-enhanced ultrasound?
    Mattei L; Prada F; Marchetti M; Gaviani P; DiMeco F
    Acta Neurochir (Wien); 2017 Dec; 159(12):2405-2408. PubMed ID: 28875373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging of Brain Tumors: Pseudoprogression, Pseudoresponse, and Delayed Effects of Chemotherapy and Radiation.
    Dietrich J; Winter SF; Klein JP
    Semin Neurol; 2017 Oct; 37(5):589-596. PubMed ID: 29207418
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.
    Fatterpekar GM; Galheigo D; Narayana A; Johnson G; Knopp E
    AJR Am J Roentgenol; 2012 Jan; 198(1):19-26. PubMed ID: 22194475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: B. Beuthien-Baumann, et al. Differentiation between recurrent tumor and radiation necrosis in a child with anaplastic ependymoma after chemotherapy and radiation therapy. Strahlenther Onkol 2003;179:819-22.
    Kortmann RD; Timmermann B; Rutkowski S; Bamberg M
    Strahlenther Onkol; 2004 Apr; 180(4):245. PubMed ID: 15057436
    [No Abstract]   [Full Text] [Related]  

  • 16. Laryngeal radionecrosis versus recurrent cancer.
    McGuirt WF
    Otolaryngol Clin North Am; 1997 Apr; 30(2):243-50. PubMed ID: 9052668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment options for sequelae following radiation treatment of brain tumors.
    Mehta S; Shah A; Jung H
    Clin Neurol Neurosurg; 2017 Dec; 163():1-8. PubMed ID: 29028584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Method for the Differential Diagnosis of Radionecrosis Versus Progression after Fractionated Stereotactic Body Radiotherapy for Brain Oligometastasis.
    Hettal L; Stefani A; Salleron J; Courrech F; Behm-Ansmant I; Constans JM; Gauchotte G; Vogin G
    Radiat Res; 2020 May; 193(5):471-480. PubMed ID: 32160109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare presentations of delayed radiation injury: a lobar hematoma and a cystic space-occupying lesion appearing more than 15 years after cranial radiotherapy: report of two cases.
    Lee JK; Chelvarajah R; King A; David KM
    Neurosurgery; 2004 Apr; 54(4):1010-3; discussion 1013-4. PubMed ID: 15046671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral radiation necrosis.
    Na A; Haghigi N; Drummond KJ
    Asia Pac J Clin Oncol; 2014 Mar; 10(1):11-21. PubMed ID: 24175987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.